University spin-out companies offer a means of commercialising valuable intellectual property (IP) and technology generated through...

On 22 July 2025, the UK Government signalled that it is likely to pivot back to indefinite recognition of CE Marking of devices. In a...

AI presents many opportunities in the women’s health space, but it can also pose considerable risks. Anyone seeking to commercialise...

Although the UK’s new R&D tax relief regime came into force on 1 April 2024, many companies have only now completed their first...

At the start of the year, our editors (Xisca Borrás, Katie Cambrook and Aida Tohala) presented to you the 12th edition of our Biotech...

Earlier this year, we reported on key considerations that parties involved in the negotiation and drafting of financial milestone...

On Wednesday, the Court of Appeal handed down a decision upholding Astellas’ enzalutamide patent. Appeals on the question of obviousness...

Government launches consultation into its national security notification regime which could see a shake up to key sensitive sectors to...

The FemTech sector — technology focused on women’s health and wellness — is experiencing rapid growth in the UK. Out of the 540 active...

We explore the complexities of navigating share option plans on both sides of the Atlantic. For companies looking to reward employees...

On 16 July 2025, the UK Government launched its Life Sciences Sector Plan as part of its Industrial Strategy (a 10-year plan aimed at...

One of the key challenges with closing the women’s health gap and expanding the number of offerings available to women (in an industry...